The world market for sex reassignment surgery is growing
by Michael Cook | 7 Jun 2020 |
The global market for sex reassignment surgery will be worth at least US$1.5 billion by 2026, according to MarketWatch.
With increasing awareness about transgender problems, favourable medical opinions and supportive government policies, the number of patients is sure to expand.
Over the past few years, the number of transitions has increased nearly four times. According to figures from the American Society of Plastic Surgeons, more than 3,000 trans masculine and trans feminine surgeries were conducted in 2016. The number of gender confirmation surgeries from male to female is 3 times greater than female to male surgeries. In 2019, male to female sex reassignment surgery accounted for a revenue of over US$184.6 million.
The growth can be attributed to the rise in medical insurance coverage for male to female gender reassignment procedures along with readily available expert opinions on the medical necessity of gender transition.
The female to male surgeries are divided into chest, genital and facial, operations. The genital surgery encompasses the surgical procedures like phalloplasty and hysterectomy that aids in in transitioning female genitals into male genitals. Male to female surgeries include breast, genital and facial procedures. The genital surgery is further divided into orchiectomy, vaginoplasty and phallectomy.
Prominent players offering different sex reassignment procedures include Yeson Voice Center, in Seoul; Sava Perovic Foundation Surgery, in Belgrade; Transgender Surgery Institute of Southern California, in Santa Monica, California; Rumer Cosmetics Surgery, in Philadelphia; Bupa Cromwell Hospital, in London; Phuket International Aesthetic Center, in Phuket, Thailand; Chettawut Plastic Surgery Center, in Bangkok; and Mount Sinai Center for Transgender Medicine and Surgery, in New York.
Michael Cook is editor of BioEdge
After the brutal killing of black man George Floyd in Minneapolis by police on May 25, demonstrations with tens of thousands of people have erupted across the United States and around the world, from Berlin to Sydney. A common sentiment reported in the American media is that “black people are dying in twin epidemics of coronavirus and racism”.
Whether #BlackLivesMatter or public health should be prioritised is sure to be the most consequential bioethics issue of the year. My guess is that hundreds, if not thousands, of lives are at stake. What do you think?
Michael Cook
Editor, BioEdge
Whether #BlackLivesMatter or public health should be prioritised is sure to be the most consequential bioethics issue of the year. My guess is that hundreds, if not thousands, of lives are at stake. What do you think?
Michael Cook
Editor, BioEdge
NEWS THIS WEEK
by Michael Cook | Jun 07, 2020
Is protesting racism a legitimate excuse for ignoring lockdowns?by Xavier Symons | Jun 07, 2020
The retractions have caused shockwaves in the global scientific community.by Michael Cook | Jun 07, 2020
Questions remain about whether this is possible this yearby Michael Cook | Jun 07, 2020
Belief in God can be an entirely rational choice, he contendsby Michael Cook | Jun 07, 2020
How do we choose between lives and livelihoods?by Michael Cook | Jun 07, 2020
At least US$1.5 billion by 2026by Michael Cook | Jun 07, 2020
Many transgender and non-binary individuals appear to be autisticIN DEPTH THIS WEEK
by Michael Cook | Jun 05, 2020
What happens if the George Floyd protesters fall sick with coronavirus?BioEdge
L1, Unit 7, 11 Lord Street · Botany, NSW 2019 · Australia
Phone: +61 2 8005 8605
Mobile: 0422-691-615
No hay comentarios:
Publicar un comentario